E2609

Eisai joins hands with Biogen on PhIII Alzheimer’s BACE trial
Fierce Pharma
Wed, 08/10/16 - 10:11 am
Eisai
Biogen
BACE inhibitors
clinical trials
Alzheimer's disease
E2609
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Bloomberg
Tue, 08/9/16 - 10:45 am
Biogen
Eisai
Alzheimer's disease
E2609
Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Biogen Idec
Merck
Alzheimer's disease
E2609
bapineuzumab
LY2886721
Eli Lilly
Tecfidera